Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...
Streetwise Reports | June 2, 2020 |

Emergency Technical Traders Market Crash Update & Video Analysis

The US stock market opened Sunday, March 8, 2020, dramatically lower. Oil collapsed 25% to near $30. Gold shot higher to levels just above $1700. All of the major US indexes were lower than 5%. As of this morning, the US major indexes are lower by 6.40%, and oil down 23%. Bo...
Chris Vermeulen | March 9, 2020 |

A billion-ton copper opportunity in Zambia

The following is a transcription of the above video, and The Market Online has edited it for clarity . Midnight Sun Mining Corp. (TSXV:MMA) is an exploration company focused on its flagship Solwezi Project in the heart of the Zambia-Congo Copper Belt. Here to ...
Ryan Dhillon | March 26, 2024 |

What A Brave S&P 500 Bulls’ Move!

Today’s article will dive deep into yesterday’s market action, including the aftermarket one. After another dreadful weekly unemployment claims report coming in at well over 5000K, the S&P 500 obliged lower, yet came back after two bouts of heav...
Monica Kingsley | April 17, 2020 |

Have the S&P 500 Bulls Convincingly Stepped Up to the Plate?

Helped by the financial sector headlines, stocks reversed higher yesterday - is the downside move drawing to a close? It might look so, but I'm not convinced yet. Despite the generally positive S&P 500 performance during the runups to Independence Day, the new Fed rules might ...
Monica Kingsley | June 26, 2020 |

The Detailed Anatomy of the S&P 500 Upswing

Today’s extensive article will evaluate the week that just passed, and examine the health of the S&P 500 advance. We’ll look both at various credit market metrics, and at the key S&P 500 sectors and ratios. Putting the pieces of the puzzle toget...
Monica Kingsley | April 20, 2020 |

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. Biopharmaceutical company Chimerix Inc....
Streetwise Reports | April 29, 2020 |

Lockdown

Sector expert Michael Ballanger interprets year-end investment tactics by looking back at a childhood encounter. "Gold is money; everything else is credit." —J.P. Morgan My first faithful dog Fido (circa 1963) and I used to play a game years ago before his eyes and ...
Streetwise Reports | November 27, 2019 |

PhaseBio Shares Are on a Tear After Reporting Phase 2a Trial Results

The clinical-stage biopharmaceutical stock surged more than 30% Wednesday following a report that PB2452 caused immediate and sustained reversal of ticagrelor in older and elderly subjects. In a press release issued September 24, PhaseBio Pharmaceuticals Inc. (PHAS...
Streetwise Reports | September 26, 2019 |

Dova Pharma Shares Rise 38% on Swedish Firm Takeover Offer

Shares of Dova Pharmaceuticals opened 38% higher today on news that the firm will be acquired by Swedish Orphan Biovitrum. The deal is reportedly valued at $915 million or $29/share. This morning Durham, N.C.-based Dova Pharmaceuticals Inc. (DOVA:NASDAQ) announced ...
Streetwise Reports | October 1, 2019 |
1 2 3 4 5 6 7 8 9 10 ...